Literature DB >> 18356441

MRI of mandibular osteonecrosis secondary to bisphosphonates.

Luis García-Ferrer1, Jose V Bagán, Vicente Martínez-Sanjuan, Sergio Hernandez-Bazan, Raquel García, Yolanda Jiménez-Soriano, Vicente Hervas.   

Abstract

OBJECTIVE: Bisphosphonates are a group of drugs used in the treatment of oncology patients with bone metastases. However, in the past few years, osteonecrosis of the jaw has been reported as a serious complication of such treatment. The objective of this study was to examine the use of MRI in the assessment of bone lesions caused by this disease.
MATERIALS AND METHODS: Fourteen patients were studied who had been treated with i.v. bisphosphonates and had developed focal lesions of osteonecrosis of the jaw. These patients were referred by the stomatology department of Hospital General Universitario de Valencia. We evaluated both the morphology and the behavior of the lesions in T1, STIR, and after the administration of gadolinium.
RESULTS: Twenty-six focal lesions were detected clinically and 36 were detected radiologically. All the clinically detected focal lesions were visible on MRI. There were 15 focal lesions detected radiologically that were not detected on clinical examination. In all patients, it was possible to assess bone involvement and involvement of the bone marrow, soft tissues, sinuses, and mandibular canal as well as the presence of adenopathy.
CONCLUSION: MRI is an effective tool in the assessment of osteonecrosis of the jaw. The significance of focal lesions detectable on radiologic examination but without clinical correlation and their progression over time remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18356441     DOI: 10.2214/AJR.07.3045

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  11 in total

1.  Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Satoru Toyosawa; Toshihiko Nagata; Masahiro Urade
Journal:  J Bone Miner Metab       Date:  2010-03-24       Impact factor: 2.626

2.  [Diagnostic imaging of drug-induced osteonecrosis of the jaw].

Authors:  V Hingst; M-A Weber
Journal:  Radiologe       Date:  2018-10       Impact factor: 0.635

3.  Cone beam computed tomography for diagnosis of bisphosphonate-related osteonecrosis of the jaw: evaluation of quantitative and qualitative image parameters.

Authors:  Roman Guggenberger; Emrah Koral; Wolfgang Zemann; Christine Jacobsen; Gustav Andreisek; Philipp Metzler
Journal:  Skeletal Radiol       Date:  2014-07-05       Impact factor: 2.199

Review 4.  Skeletal complications of bisphosphonate use: what the radiologist should know.

Authors:  A E Haworth; J Webb
Journal:  Br J Radiol       Date:  2012-10       Impact factor: 3.039

5.  Bisphosphonate-induced osteonecrosis of the jaw: comparison of disease extent on contrast-enhanced MR imaging, [18F] fluoride PET/CT, and conebeam CT imaging.

Authors:  R Guggenberger; D R Fischer; P Metzler; G Andreisek; D Nanz; C Jacobsen; D T Schmid
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-06       Impact factor: 3.825

6.  Evaluation of BP-ONJ in osteopenic and healthy sheep: comparing ZTE-MRI with µCT.

Authors:  Pit Voss; Ute Ludwig; Philipp Poxleitner; Veronika Bergmaier; Nora El-Shafi; Dominik von Elverfeldt; Vincent Stadelmann; Jan-Bernd Hövener; Tabea Flügge
Journal:  Dentomaxillofac Radiol       Date:  2016-02-05       Impact factor: 2.419

7.  Imaging findings in bisphosphonate-induced osteonecrosis of the jaws.

Authors:  Katarina Surlan Popovic; Miha Kocar
Journal:  Radiol Oncol       Date:  2010-06-24       Impact factor: 2.991

Review 8.  Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.

Authors:  Pongsapak Wongratwanich; Kiichi Shimabukuro; Masaru Konishi; Toshikazu Nagasaki; Masahiko Ohtsuka; Yoshikazu Suei; Takashi Nakamoto; Rinus G Verdonschot; Tomohiko Kanesaki; Pipop Sutthiprapaporn; Naoya Kakimoto
Journal:  Dentomaxillofac Radiol       Date:  2021-01-15       Impact factor: 3.525

Review 9.  Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ).

Authors:  Britt-Isabelle Berg; Andreas A Mueller; Marcello Augello; Scott Berg; Claude Jaquiéry
Journal:  Dent J (Basel)       Date:  2016-09-02

10.  18F-Fluoride PET/CT Imaging of Medication-Related Osteonecrosis of the Jaw in Conservative Treatment-A Case Report.

Authors:  Christian Philipp Reinert; Christina Pfannenberg; Sergios Gatidis; Christian la Fougère; Konstantin Nikolaou; Sebastian Hoefert
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.